Computational Design and In Silico Evaluation of Novel Cannabinoids Targeting the CB2 Receptor: Chemical Reactivity, Binding Mode, and Predicted ADMET Profile

The CB2 cannabinoid receptor represents an attractive therapeutic target due to its immunomodulatory relevance and its lack of psychoactive effects. Here, we applied an integrated in silico approach to design and prioritize JWH-015-derived ligands with improved CB2 affinity and pharmacokinetic properties. Density functional theory calculations (PBE/TZVP/GEN-A2*) provided global and local reactivity descriptors that were correlated with predicted binding interactions obtained from a consensus docking strategy (AutoDock4, Vina, and Smina). Structural stability and interaction persistence were further assessed by nine 500-ns molecular dynamics simulations. Among the designed structures, analog 9 exhibited the most persistent and favorable interactions with key CB2 residues throughout the simulations, supporting its suitability as a lead candidate. In contrast, analogs 12 and 20 displayed notably safer biosafety profiles, indicating value as alternative scaffolds for further chemical exploration. These results support the rational design of CB2-targeted ligands and identify structural features that may guide future synthesis and biological evaluation.

Authors

Institutions

Publication Details

Journal
ChemMedChem
Published
2026-11-13
DOI
https://doi.org/10.1002/cmdc.70542
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Computational Design and In Silico Evaluation of Novel Cannabinoids Targeting the CB2 Receptor: Chemical Reactivity, Binding Mode, and Predicted ADMET Profile

Jesús A. Lara‐Cerón, Daniela Navarro, Jhoan Piermattey, Sara A. Cortés-Llamas et al.
ChemMedChem
Computational Drug Discovery Methods
article

Computational Design and In Silico Evaluation of Novel Cannabinoids Targeting the CB2 Receptor: Chemical Reactivity, Binding Mode, and Predicted ADMET Profile

Jesús A. Lara‐Cerón, Daniela Navarro, Jhoan Piermattey, Sara A. Cortés-Llamas, Ulises Osuna‐Martínez, Roberto Flores‐Moreno, Ricardo Vivas‐Reyes
article en

Abstract

The CB2 cannabinoid receptor represents an attractive therapeutic target due to its immunomodulatory relevance and its lack of psychoactive effects. Here, we applied an integrated in silico approach to design and prioritize JWH-015-derived ligands with improved CB2 affinity and pharmacokinetic properties. Density functional theory calculations (PBE/TZVP/GEN-A2*) provided global and local reactivity descriptors that were correlated with predicted binding interactions obtained from a consensus docking strategy (AutoDock4, Vina, and Smina). Structural stability and interaction persistence were further assessed by nine 500-ns molecular dynamics simulations. Among the designed structures, analog 9 exhibited the most persistent and favorable interactions with key CB2 residues throughout the simulations, supporting its suitability as a lead candidate. In contrast, analogs 12 and 20 displayed notably safer biosafety profiles, indicating value as alternative scaffolds for further chemical exploration. These results support the rational design of CB2-targeted ligands and identify structural features that may guide future synthesis and biological evaluation.

ChemMedChemVol. 21(22)
Universidad de Cartagena (CO), Universidad de Guadalajara (MX), Universidad Autónoma de Sinaloa (MX)
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon